南華早報Could new US investment curbs complicate China’s biotech licensing surge?
作者 Xinmei Shen全文約 4,160 字
文章摘要
南華早報 · 文章頁摘要Licensing deals untouched for now, but proposed US investment rules and new Chinese export curbs may impact biotech expansion, analysts say.
Chinese biotech firms face fresh headwinds in their global expansion as Washington’s proposed outbound investment restrictions threaten to disrupt dea...